Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024

BUY
$3.52 - $9.59 $5.87 Million - $16 Million
1,667,406 Added 33.54%
6,638,910 $24.9 Million
Q4 2023

Feb 14, 2024

BUY
$5.97 - $10.36 $4.32 Million - $7.5 Million
723,785 Added 17.04%
4,971,504 $48.8 Million
Q3 2023

Nov 14, 2023

BUY
$8.23 - $13.93 $1.43 Million - $2.42 Million
173,555 Added 4.26%
4,247,719 $35.5 Million
Q2 2023

Aug 14, 2023

BUY
$9.97 - $14.05 $603,653 - $850,685
60,547 Added 1.51%
4,074,164 $54.2 Million
Q1 2023

May 15, 2023

BUY
$7.94 - $12.02 $8,678 - $13,137
1,093 Added 0.03%
4,013,617 $46.5 Million
Q4 2022

Feb 21, 2023

SELL
$5.67 - $11.2 $60,941 - $120,377
-10,748 Reduced 0.27%
4,012,524 $32.8 Million
Q3 2022

Nov 14, 2022

BUY
$3.93 - $8.57 $192,550 - $419,887
48,995 Added 1.23%
4,023,272 $23.4 Million
Q2 2022

Aug 15, 2022

BUY
$4.02 - $10.43 $535,669 - $1.39 Million
133,251 Added 3.47%
3,974,277 $17.6 Million
Q1 2022

May 16, 2022

BUY
$8.43 - $20.9 $16.4 Million - $40.6 Million
1,941,270 Added 102.19%
3,841,026 $35 Million
Q4 2021

Feb 11, 2022

BUY
$19.26 - $30.08 $32.6 Million - $50.9 Million
1,692,396 Added 816.16%
1,899,756 $38.9 Million
Q3 2021

Nov 12, 2021

SELL
$24.86 - $35.02 $89,247 - $125,721
-3,590 Reduced 1.7%
207,360 $5.3 Million
Q2 2021

Aug 13, 2021

BUY
$22.3 - $36.02 $462,568 - $747,162
20,743 Added 10.91%
210,950 $7.38 Million
Q1 2021

May 14, 2021

SELL
$26.38 - $51.15 $23.5 Million - $45.5 Million
-889,419 Reduced 82.38%
190,207 $6.34 Million
Q4 2020

Feb 16, 2021

BUY
$10.5 - $28.5 $11.3 Million - $30.7 Million
1,077,750 Added 57449.36%
1,079,626 $28 Million
Q2 2020

Aug 11, 2020

BUY
$2.65 - $4.03 $4,971 - $7,560
1,876 New
1,876 $6,000

Others Institutions Holding PACB

About PACIFIC BIOSCIENCES OF CALIFORNIA, INC.


  • Ticker PACB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 224,840,992
  • Market Cap $438M
  • Description
  • Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits design...
More about PACB
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.